[The clinical significance of renal functional reserve]

Area of Science:

• Nephrology
• Internal Medicine
• Clinical Research

Background:

• Intraglomerular hypertension is a key factor in the progression of chronic kidney diseases.
• Identifying patients at risk is essential for timely intervention.
• Chronic glomerulonephritis (CGN) encompasses various conditions with potential for elevated intraglomerular pressure.

Purpose of the Study:

• To identify clinico-laboratory findings and clinical syndromes indicative of intraglomerular hypertension in CGN patients.
• To define risk groups within the CGN population susceptible to developing intraglomerular hypertension.
• To guide therapeutic strategies for managing intraglomerular hypertension in nonimmune CGN progression.

Main Methods:

• Analysis of clinico-laboratory findings in CGN patients.
• Assessment of clinical syndromes associated with intraglomerular hypertension.
• Evaluation of markers such as renal functional reserve.

Main Results:

• CGN patients with urinary syndrome, arterial hypertension, nephrotic disease, and serum creatinine >1.4 mg/dL are at risk.
• Specific patterns of renal damage, including focal-segmental glomerulosclerosis or fibroplastic glomerulonephritis, indicate higher risk.
• Low or absent renal functional reserve is a marker for intraglomerular hypertension.

Conclusions:

• Specific clinical and laboratory parameters can identify CGN patients at risk of intraglomerular hypertension.
• Patients identified in risk groups require management to reduce intraglomerular pressure.
• Targeted pharmacological interventions are recommended for CGN patients with nonimmune progression due to elevated intraglomerular pressure.